The role of estrogen and androgen receptors in bone health and disease

Nature Reviews Endocrinology

Volumn 9, Issue 12, 2013, Pages 699-712

  Manolagas, Stavros C ^a   O'Brien, Charles A ^a   Almeida, Maria ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; FAS LIGAND; INTERLEUKIN 7; LIOTHYRONINE; OSTEOCLAST DIFFERENTIATION FACTOR; SOMATOMEDIN C; SUPPRESSOR OF CYTOKINE SIGNALING 2; TESTOSTERONE; THYROXINE;

ANDROGEN INSENSITIVITY SYNDROME; APOPTOSIS; B LYMPHOCYTE; BONE CHARACTERISTICS AND FUNCTIONS; BONE DISEASE; BONE GROWTH; BONE MARROW CELL; BONE MASS; BONE TURNOVER; CARTILAGE CELL; CORTICAL BONE; ENCHONDRAL OSSIFICATION; EPIPHYSIS; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN THERAPY; GENETIC TRANSCRIPTION; GROWTH PLATE; HOMEOSTASIS; HYPOGONADOTROPIC HYPOGONADISM; LIOTHYRONINE BLOOD LEVEL; LOSS OF FUNCTION MUTATION; MECHANICAL STRESS; NONHUMAN; ORCHIECTOMY; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PATHOGENESIS; PERIOSTEUM; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SEX DIFFERENCE; SEXUAL MATURATION; T LYMPHOCYTE; THYROXINE BLOOD LEVEL; TRABECULAR BONE; WNT SIGNALING PATHWAY;

ANIMALS; ESTROGEN RECEPTOR ALPHA; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, ANDROGEN;

EID: 84888205228     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.179     Document Type: Review

References (173)

1. Manolagas, S. C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21, 115-137 (2000). (Pubitemid 32275592)
2. Riggs, B. L., Khosla, S. & Melton, L. J. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in ageing men. J. Bone Miner. Res. 13, 763-773 (1998). (Pubitemid 28224192)
3. Han, Z. H., Palnitkar, S., Rao, D. S., Nelson, D. & Parfitt, A. M. Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss. J. Bone Miner. Res. 12, 498-508 (1997). (Pubitemid 27155209)
4. Katznelson, L. et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J. Clin. Endocrinol. Metab. 81, 4358-4365 (1996). (Pubitemid 26412044)
5. Daniell, H. W. Osteoporosis after orchiectomy for prostate cancer. J. Urol. 157, 439-444 (1997). (Pubitemid 27026812)
6. Falahati-Nini, A. et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J. Clin. Invest. 106, 1553-1560 (2000). (Pubitemid 32038592)
7. Lacey, D. L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176 (1998). (Pubitemid 28180851)
8. Kearns, A. E., Khosla, S. & Kostenuik, P. J. Receptor activator of nuclear factor κB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr. Rev. 29, 155-192 (2008). (Pubitemid 351519689)
9. Jilka, R. L. et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257, 88-91 (1992).
10. Bellido, T. et al. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J. Clin. Invest. 95, 2886-2895 (1995).
11. Kousteni, S. et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298, 843-846 (2002). (Pubitemid 35231540)
12. Beato, M. & Klug, J. Steroid hormone receptors: an update. Hum. Reprod. Update. 6, 225-236 (2000). (Pubitemid 30348891)
13. Kumar, R. & Thompson, E. B. The structure of the nuclear hormone receptors. Steroids 64, 310-319 (1999). (Pubitemid 29284331)
14. Gallet, M. & Vanacker, J. M. ERR receptors as potential targets in osteoporosis. Trends Endocrinol. Metab. 21, 637-641 (2010).
15. Tsai, M. J. & O'Malley, B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486 (1994).
16. Kousteni, S. et al. Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J. Clin. Invest. 111, 1651-1664 (2003). (Pubitemid 38057747)
17. Hammes, S. R. & Levin, E. R. Extranuclear steroid receptors: nature and actions. Endocr. Rev. 28, 726-741 (2007). (Pubitemid 350294293)
18. Rai, D., Frolova, A., Frasor, J., Carpenter, A. E. & Katzenellenbogen, B. S. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells. Mol. Endocrinol. 19, 1606-1617 (2005). (Pubitemid 41002989)
19. Kawano, H. et al. Suppressive function of androgen receptor in bone resorption. Proc. Natl Acad. Sci. USA 100, 9416-9421 (2003). (Pubitemid 37033943)
20. Yeh, S. et al. Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc. Natl Acad. Sci. USA 99, 13498-13503 (2002). (Pubitemid 35215410)
21. Vico, L. & Vanacker, J. M. Sex hormones and their receptors in bone homeostasis: insights from genetically modified mouse models. Osteoporos. Int. 21, 365-372 (2010).
22. Harris, H. A. Estrogen receptor-β: recent lessons from in vivo studies. Mol. Endocrinol. 21, 1-13 (2007). (Pubitemid 46041687)
23. Kronenberg, H. M. Developmental regulation of the growth plate. Nature 423, 332-336 (2003). (Pubitemid 40852707)
24. van der Eerden, B. C., Karperien, M. & Wit, J. M. Systemic and local regulation of the growth plate. Endocr. Rev. 24, 782-801 (2003). (Pubitemid 38067699)
25. Parfitt, A. M. Misconceptions (1): epiphyseal fusion causes cessation of growth. Bone 30, 337-339 (2002). (Pubitemid 34150155)
26. Smith, E. P. et al. Impact on bone of an estrogen receptor-α gene loss of function mutation. J. Clin. Endocrinol. Metab. 93, 3088-3096 (2008).
27. MacGillivray, M. H., Morishima, A., Conte, F., Grumbach, M. & Smith, E. P. Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor. Horm. Res. 49 (Suppl. 1), 2-8 (1998). (Pubitemid 28130117)
28. Carani, C. et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337, 91-95 (1997). (Pubitemid 27284394)
29. Bilezikian, J. P., Morishima, A., Bell, J. & Grumbach, M. M. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N. Engl. J. Med. 339, 599-603 (1998). (Pubitemid 28385657)
30. Tajima, Y., Yokose, S., Kawasaki, M. & Takuma, T. Ovariectomy causes cell proliferation and matrix synthesis in the growth plate cartilage of the adult rat. Histochem. J. 30, 467-472 (1998). (Pubitemid 28341682)
31. Almeida, M. et al. Estrogen receptor-alpha signaling in osteoblast progenitors stimulates cortical bone accrual. J. Clin. Invest. 123, 394-404 (2013).
32. Borjesson, A. E. et al. The role of estrogen receptor-α and its activation function-1 for growth plate closure in female mice. Am. J. Physiol. Endocrinol. Metab. 302, E1381-E1389 (2012).
33. Borjesson, A. E. et al. The role of estrogen receptor α in growth plate cartilage for longitudinal bone growth. J. Bone Miner. Res. 25, 2690-2700 (2010).
34. Bartell, S. M. et al. Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass. Mol. Endocrinol. 27, 649-656 (2013).
35. Kousteni, S. et al. Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Mol. Cell Biol. 27, 1516-1530 (2007). (Pubitemid 46239831)
36. Callewaert, F., Sinnesael, M., Gielen, E., Boonen, S. & Vanderschueren, D. Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading. J. Endocrinol. 207, 127-134 (2010).
37. Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor α and induction of Fas ligand in osteoclasts. Cell 130, 811-823 (2007). (Pubitemid 47332572)
38. Martin-Millan, M. et al. The estrogen receptor α in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol. Endocrinol. 24, 323-334 (2010).
39. Almeida, M., Han, L., Martin-Millan, M., O'Brien, C. A. & Manolagas, S. C. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting β-catenin from T cell factor-to-forkhead box O-mediated transcription. J. Biol. Chem. 282, 27298-27305 (2007). (Pubitemid 47501978)
40. Almeida, M., Ambrogini, E., Han, L., Manolagas, S. C. & Jilka, R. L. Increased lipid oxidation causes oxidative stress, increased PPAR? expression and diminished pro-osteogenic Wnt signaling in the skeleton. J. Biol. Chem. 284, 27438-27448 (2009).
41. Bienz, M. & Clevers, H. Armadillo/ β -catenin signals in the nucleus-proof beyond a reasonable doubt? Nat. Cell Biol. 5, 179-182 (2003). (Pubitemid 36322238)
42. Rodda, S. J. & McMahon, A. P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133, 3231-3244 (2006). (Pubitemid 44404346)
43. Almeida, M. et al. Estrogens attenuate oxidative stress, osteoblast differentiation and apoptosis by DNA binding-independent actions of the ERα. J. Bone Mineral. Res. 25, 769-781 (2010).
44. DiGregorio, G. et al. Attenuation of the self-renewal of transit amplifying osteoblast progenitors in the murine bone marrow by 17 J -estradiol. J. Clin. Invest. 107, 803-812 (2001).
45. Sottile, V., Seuwen, K. & Kneissel, M. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARυ agonist BRL49653 (rosiglitazone). Calcif. Tissue Int. 75, 329-337 (2004). (Pubitemid 40064235)
46. Syed, F. A. et al. Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos. Int. 19, 1323-1330 (2008).
47. Manolagas, S. C. & Jilka, R. L. Bone marrow, cytokines, and bone remodeling-emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 332, 305-311 (1995).
48. Khosla, S., Oursler, M. J. & Monroe, D. G. Estrogen and the skeleton. Trends Endocrinol. Metab. 23, 576-581 (2012).
49. Tomkinson, A., Reeve, J., Shaw, R. W. & Noble, B. S. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J. Clin. Endocrinol. Metab. 82, 3128-3135 (1997). (Pubitemid 27385687)
50. Kousteni, S. et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104, 719-730 (2001). (Pubitemid 32241022)
51. Almeida, M. et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J. Biol. Chem. 282, 27285-27297 (2007). (Pubitemid 47501960)
52. Windahl, S. H. et al. Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice. Proc. Natl Acad. Sci. USA 110, 2294-2299 (2013).
53. Mä ättä, J. A. et al. Inactivation of estrogen receptor α in bone-forming cells induces bone loss in female mice. FASEB J. 27, 478-488 (2013).
54. Finkelstein, J. S. et al. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann. Intern. Med. 106, 354-361 (1987). (Pubitemid 17029484)
55. Marcus, R. et al. The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome. J. Clin. Endocrinol. Metab. 85, 1032-1037 (2000). (Pubitemid 32269345)
56. Venken, K. et al. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. J. Bone Miner. Res. 21, 576-585 (2006).
57. Vanderschueren, D., Venken, K., Ophoff, J., Bouillon, R. & Boonen, S. Clinical Review: sex steroids and the periosteum-reconsidering the roles of androgens and estrogens in periosteal expansion. J. Clin. Endocrinol. Metab. 91, 378-382 (2006). (Pubitemid 43236896)
58. Windahl, S. H. et al. Reduced bone mass and muscle strength in male 5α-reductase type 1 inactivated mice. PLoS ONE 6, e21402 (2011).
59. Sinnesael, M. et al. Androgen receptor (AR) in osteocytes is important for the maintenance of male skeletal integrity: evidence from targeted AR disruption in mouse osteocytes. J. Bone Miner. Res. 27, 2535-2543 (2012).
60. Chiang, C. et al. Mineralization and bone resorption are regulated by the androgen receptor in male mice. J. Bone Miner. Res. 24, 621-631 (2009).
61. Notini, A. J. et al. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. J. Bone Miner. Res. 22, 347-356 (2007). (Pubitemid 46797117)
62. Horowitz, M. C., Fretz, J. A. & Lorenzo, J. A. How B cells influence bone biology in health and disease. Bone 47, 472-479 (2010).
63. Pacifici, R. Role of T cells in ovariectomy induced bone loss-revisited. J. Bone Miner. Res. 27, 231-239 (2012).
64. Li, J. Y. et al. Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc. Natl Acad. Sci. USA 108, 768-773 (2011).
65. Toraldo, G., Roggia, C., Qian, W. P., Pacifici, R. & Weitzmann, M. N. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor κB ligand and tumor necrosis factor α from T cells. Proc. Natl Acad. Sci. USA 100, 125-130 (2003). (Pubitemid 36078040)
66. Eghbali-Fatourechi, G. et al. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J. Clin. Invest. 111, 1221-1230 (2003). (Pubitemid 36519939)
67. D'Amelio, P. et al. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone 43, 92-100 (2008).
68. Lee, S. K. et al. T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J. Bone Miner. Res. 21, 1704-1712 (2006).
69. Miyaura, C. et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc. Natl Acad. Sci. USA 94, 9360-9365 (1997). (Pubitemid 27357834)
70. Masuzawa, T. et al. Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J. Clin. Invest. 94, 1090-1097 (1994). (Pubitemid 24286451)
71. Ishimi, Y. et al. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 140, 1893-1900 (1999). (Pubitemid 29149263)
72. Onoe, Y. et al. Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. J. Bone Miner. Res. 15, 541-549 (2000). (Pubitemid 30134099)
73. Tyagi, A. M. et al. Daidzein prevents the increase in CD4+CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect. PLoS ONE 6, e21216 (2011).
74. Lee, S. K. et al. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss. J. Bone Miner. Res. 21, 695-702 (2006).
75. Wilson, C. A., Mrose, S. A. & Thomas, D. W. Enhanced production of B lymphocytes after castration. Blood 85, 1535-1539 (1995).
76. Li, Y., Li, A., Yang, X. & Weitzmann, M. N. Ovariectomy-induced bone loss occurs independently of B cells. J. Cell Biochem. 100, 1370-1375 (2007). (Pubitemid 46515571)
77. Onal, M. et al. Receptor activator of nuclear factor κB Ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. J. Biol. Chem. 287, 29851-29860 (2012).
78. Taxel, P. et al. Estradiol rapidly inhibits osteoclastogenesis and RANKL expression in bone marrow cultures in postmenopausal women: a pilot study. Osteoporos. Int. 19, 193-199 (2008).
79. Samy, T. S., Schwacha, M. G., Cioffi, W. G., Bland, K. I. & Chaudry, I. H. Androgen and estrogen receptors in splenic T lymphocytes: effects of flutamide and trauma-hemorrhage. Shock 14, 465-470 (2000).
80. Igarashi, H., Kouro, T., Yokota, T., Comp., P. C. & Kincade, P. W. Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proc. Natl Acad. Sci. USA 98, 15131-15136 (2001). (Pubitemid 34013981)
81. Lelu, K. et al. Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of TH1 and TH17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J. Immunol. 187, 2386-2393 (2011).
82. Altuwaijri, S. et al. Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. Mol. Endocrinol. 23, 444-453 (2009).
83. Bagamasbad, P. & Denver, R. J. Mechanisms and significance of nuclear receptor auto-and cross-regulation. Gen. Comp. Endocrinol. 170, 3-17 (2011).
84. Krum, S. A. et al. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 27, 535-545 (2008). (Pubitemid 351225684)
85. Galien, R. & Garcia, T. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-κB site. Nucleic Acids Res. 25, 2424-2429 (1997). (Pubitemid 27303703)
86. Poli, V. et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13, 1189-1196 (1994). (Pubitemid 24074725)
87. Manolagas, S. C. et al. Kinase-mediated transcription, activators of nongenotropic estrogen-like signaling (ANGELS), and osteoporosis: a different perspective on the HRT dilemma. Kidney Int. Suppl. 91, S41-S49 (2004). (Pubitemid 39281714)
88. Manolagas, S. C. & Kousteni, S. Perspective: nonreproductive sites of action of reproductive hormones. Endocrinology 142, 2200-2204 (2001). (Pubitemid 32473072)
89. Windahl, S. H. et al. Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor. J. Clin. Invest. 116, 2500-2509 (2006). (Pubitemid 44330149)
90. Manolagas, S. C. et al. Response to Windahl et al. J. Clin. Invest. 116, 2834 (2006).
91. Page, S. T., Marck, B. T., Tolliver, J. M. & Matsumoto, A. M. Tissue selectivity of the anabolic steroid, 19-nor-4-androstenediol-3β, 17 β-diol in male Sprague Dawley rats: selective stimulation of muscle mass and bone mineral density relative to prostate mass. Endocrinology 149, 1987-1993 (2008). (Pubitemid 351468363)
92. Wessler, S., Otto, C., Wilck, N., Stangl, V. & Fritzemeier, K. H. Identification of estrogen receptor ligands leading to activation of non-genomic signaling pathways while exhibiting only weak transcriptional activity. J. Steroid Biochem. Mol. Biol. 98, 25-35 (2006). (Pubitemid 43113241)
93. Otto, C. et al. In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro. J. Steroid Biochem. Mol. Biol. 111, 95-100 (2008).
94. Harrington, W. R. et al. Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol. Endocrinol. 20, 491-502 (2006). (Pubitemid 43291204)
95. Kim, S. H. & Katzenellenbogen, J. A. Hormone-PAMAM dendrimer conjugates: polymer dynamics and tether structure affect ligand access to receptors. Angew. Chem. Int. Ed. Engl. 45, 7243-7248 (2006). (Pubitemid 44748311)
96. Chambliss, K. L. et al. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J. Clin. Invest. 120, 2319-2330 (2010).
97. Almeida, M., Han, L., Ambrogini, E., Bartell, S. M. & Manolagas, S. C. Oxidative stress stimulates apoptosis and activates NF-κB in osteoblastic cells via a PKCβ/p66shc signaling cascade: counter regulation by estrogens or androgens. Mol. Endocrinol. 20, 2030-2037 (2010).
98. Mödder, U. I. et al. Effects of loss of steroid receptor coactivator-1 on the skeletal response to estrogen in mice. Endocrinology 145, 913-921 (2004). (Pubitemid 38183835)
99. Börjesson, A. E. et al. Roles of transactivating functions 1 and 2 of estrogen receptor-α in bone. Proc. Natl Acad. Sci. USA 108, 6288-6293 (2011).
100. Frost, H. M. Bone "mass" and the "mechanostat": a proposal. Anat. Rec. 219, 1-9 (1987).
101. Aarden, E. M., Burger, E. H. & Nijweide, P. J. Function of osteocytes in bone. J. Cell. Biochem. 55, 287-299 (1994). (Pubitemid 24218803)
102. Manolagas, S. C. & Parfitt, A. M. For. whom the bell tolls: distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases. Bone 54, 272-278 (2013).
103. Lee, K. C., Jessop, H., Suswillo, R., Zaman, G. & Lanyon, L. E. The adaptive response of bone to mechanical loading in female transgenic mice is deficient in the absence of estrogen receptor-α and -β. J. Endocrinol. 182, 193-201 (2004). (Pubitemid 39199003)
104. Armstrong, V. J. et al. Wnt/β-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor α. J. Biol. Chem. 282, 20715-20727 (2007). (Pubitemid 47100049)
105. Aguirre, J. I. et al. A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction. J. Biol. Chem. 282, 25501-25508 (2007). (Pubitemid 47372838)
106. Tatsumi, S. et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell. Metab. 5, 464-475 (2007). (Pubitemid 46825494)
107. Sugiyama, T., Galea, G. L., Lanyon, L. E. & Price, J. S. Mechanical loading-related bone gain is enhanced by tamoxifen but unaffected by fulvestrant in female mice. Endocrinology 151, 5582-5590 (2010).
108. Windahl, S. H. et al. Estrogen receptor-α is required for the osteogenic response to mechanical loading in a ligand-independent manner involving its activation function 1 but not 2. J. Bone Miner. Res. 28, 291-301 (2013).
109. Callewaert, F. et al. Androgen receptor disruption increases the osteogenic response to mechanical loading in male mice. J. Bone Miner. Res. 25, 124-131 (2010).
110. Robinson, J. A. et al. Wnt/β-catenin signaling is a normal physiological response to mechanical loading in bone. J. Biol. Chem. 281, 31720-31728 (2006). (Pubitemid 46043263)
111. Tu, X. et al. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone 50, 209-217 (2012).
112. Sawakami, K. et al. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J. Biol. Chem. 281, 23698-23711 (2006). (Pubitemid 44274145)
113. Parfitt, A. M., Travers, R., Rauch, F. & Glorieux, F. H. Structural and cellular changes during bone growth in healthy children. Bone 27, 487-494 (2000).
114. Nicks, K. M. et al. Three-dimensional structural analysis of the proximal femur in an age-stratified sample of women. Bone 55, 179-188 (2013).
115. Shahnazari, M. et al. Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. Bone 50, 628-637 (2012).
116. Syed, F. A. et al. Effects of chronic estrogen treatment on modulating age-related bone loss in female mice. J. Bone Miner. Res. 25, 2438-2446 (2010).
117. Zebaze, R. M. et al. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet 375, 1729-1736 (2010).
118. Emerton, K. B. et al. Osteocyte apoptosis and control of bone resorption following ovariectomy in mice. Bone 46, 577-583 (2010).
119. Jilka, R. L. et al. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone 44, 275-286 (2009).
120. Hui, S. L., Slemenda, C. W. & Johnston, C. C. Jr. The contribution of bone loss to postmenopausal osteoporosis. Osteoporos. Int. 1, 30-34 (1990).
121. Seeman, E. Reduced bone density in women with fractures: contribution of low peak bone density and rapid bone loss. Osteoporos. Int. 4 (Suppl. 1), 15-25 (1994).
122. Duan, Y., Parfitt, A. & Seeman, E. Vertebral bone mass, size, and volumetric density in women with spinal fractures. J. Bone Miner. Res. 14, 1796-1802 (1999). (Pubitemid 29455829)
123. Bikle, D. D., Halloran, B. P. & Morey-Holton, E. Spaceflight and the skeleton: lessons for the earthbound. Gravit. Space Biol. Bull. 10, 119-135 (1997).
124. Carmeliet, G., Vico, L. & Bouillon, R. Space flight: a challenge for normal bone homeostasis. Crit. Rev. Eukaryot. Gene Expr. 11, 131-144 (2001). (Pubitemid 32994863)
125. Marcus, R. in Principles of Bone Biology (eds Bilezikian, J. P., Raisz L. G & Rodan, G. A.) 1477-1488 (Academic, 2002).
126. Bikle, D. D., Sakata, T. & Halloran, B. P. The impact of skeletal unloading on bone formation. Gravit. Space Biol. Bull. 16, 45-54 (2003).
127. Wolff, J. Das Gesetz der Transformation der Knochen [German]. (Springer, 1892).
128. Bonewald, L. F. The amazing osteocyte. J. Bone Miner. Res. 26, 229-238 (2011).
129. Qiu, S., Rao, D. S., Palnitkar, S. & Parfitt, A. M. Reduced iliac cancellous osteocyte density in patients with osteoporotic vertebral fracture. J. Bone Miner. Res. 18, 1657-1663 (2003). (Pubitemid 37022924)
130. Rosen, J. M. Hormone receptor patterning plays a critical role in normal lobuloalveolar development and breast cancer progression. Breast Dis. 18, 3-9 (2003). (Pubitemid 39193327)
131. Kleinberg, D. L. & Barcellos-Hoff, M. H. The pivotal role of insulin-like growth factor I in normal mammary development. Endocrinol. Metab. Clin. North Am. 40, 461-471 (2011).
132. Bolamperti, S. et al. 17β-Estradiol positively modulates growth hormone signalling through the reduction of SOCS2 negative feedback in human osteoblasts. Bone 55, 84-92 (2013).
133. Frost, H. M. Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff's Law: the bone modeling problem. Anat. Rec. 226, 403-413 (1990). (Pubitemid 20134040)
134. Parfitt, A. M. The two faces of growth: benefits and risks to bone integrity. Osteoporos. Int. 4, 382-398 (1994).
135. Aguirre, J. I. et al. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J. Bone Miner. Res. 21, 605-615 (2006).
136. Cardoso, L. et al. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J. Bone Miner. Res. 24, 597-605 (2009).
137. Seeman, E. Periosteal bone formation-a neglected determinant of bone strength. N. Engl. J. Med. 349, 320-323 (2003). (Pubitemid 36886235)
138. Callewaert, F. et al. Sexual dimorphism in cortical bone size and strength but not density is determined by independent and time-specific actions of sex steroids and IGF-1: evidence from pubertal mouse models. J. Bone Miner. Res. 25, 617-626 (2010).
139. Bouillon, R., Bex, M., Vanderschueren, D. & Boonen, S. Estrogens are essential for male pubertal periosteal bone expansion. J. Clin. Endocrinol. Metab. 89, 6025-6029 (2004). (Pubitemid 39628410)
140. Rochira, V. et al. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone. Bone 40, 1662-1668 (2007). (Pubitemid 46779001)
141. Turner, R. T., Wakley, G. K. & Hannon, K. S. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J. Orthop. Res. 8, 612-617 (1990). (Pubitemid 20319518)
142. Sims, N. A. et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-β in bone remodeling in females but not in males. Bone 30, 18-25 (2002). (Pubitemid 34044296)
143. Callewaert, F., Boonen, S. & Vanderschueren, D. Sex steroids and the male skeleton: a tale of two hormones. Trends Endocrinol. Metab. 21, 89-95 (2010).
144. Callewaert, F. et al. Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-α. FASEB J. 23, 232-240 (2009).
145. Wiren, K. M. et al. Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis: a model for compartment-specific androgen action in the skeleton. Bone 43, 440-451 (2008).
146. Vanderschueren, D., Venken, K., Ophoff, J., Bouillon, R. & Boonen, S. Sex steroids and the periosteum: reconsidering the role of androgens and estrogens in periosteal expansion. J. Clin. Endocrinol. Metab. 91, 378-382 (2006). (Pubitemid 43236896)
147. Saxon, L. K. & Turner, C. H. Estrogen receptor β: the antimechanostat? Bone 36, 185-192 (2005).
148. Bagamasbad, P. & Denver, R. J. Mechanisms and significance of nuclear receptor auto-and cross-regulation. Gen. Comp. Endocrinol. 170, 3-17 (2011).
149. Ihionkhan, C. E. et al. Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ. Res. 91, 814-820 (2002). (Pubitemid 35285079)
150. Reid, G., Denger, S., Kos, M. & Gannon, F. Human estrogen receptor-α: regulation by synthesis, modification and degradation. Cell. Mol. Life Sci. 59, 821-831 (2002). (Pubitemid 34628243)
151. Manolagas, S. C. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr. Rev. 31, 266-300 (2010).
152. Khosla, S., Melton, L. J., III & Riggs, B. L. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J. Bone Miner. Res. 26, 441-451 (2011).
153. Looker, A. C. et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos. Int. 8, 468-489 (1998). (Pubitemid 28486716)
154. Nicks, K. M. et al. Relationship of age to bone microstructure independent of areal bone mineral density. J. Bone Miner. Res. 27, 637-644 (2012).
155. Parfitt, A. M., Villanueva, A. R., Foldes, J. & Rao, D. S. Relations between histologic indices of bone formation: implications for the pathogenesis of spinal osteoporosis. J. Bone Miner. Res. 10, 466-473 (1995).
156. Manolagas, S. C. & Parfitt, A. M. What old means to bone. Trends Endocrinol. Metab. 21, 369-374 (2010).
157. Jilka, R. L. et al. Decreased oxidative stress and greater bone anabolism in the aged, as compared to the young, murine skeleton by parathyroid hormone. Aging Cell 9, 851-867 (2010).
158. Ahlborg, H. G., Johnell, O., Turner, C. H., Rannevik, G. & Karlsson, M. K. Bone loss and bone size after menopause. N. Engl. J. Med. 349, 327-334 (2003). (Pubitemid 36886238)
159. Rossouw, J. E. et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333 (2002). (Pubitemid 34761611)
160. [No authors listed] Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 17, 242-255 (2010).
161. Hui, S. L., Slemenda, C. W. & Johnston, C. C. Jr. Age and bone mass as predictors of fracture in a prospective study. J. Clin. Invest. 81, 1804-1809 (1988).
162. Walston, J. D. Sarcopenia in older adults. Curr. Opin. Rheumatol 24, 623-627 (2012).
163. Karasik, D. & Kiel, D. P. Evidence for pleiotropic factors in genetics of the musculoskeletal system. Bone 46, 1226-1237 (2010).
164. Janssen, I., Heymsfield, S. B. & Ross, R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J. Am. Geriatr. Soc. 50, 889-896 (2002). (Pubitemid 34496687)
165. Weinstein, R. S. et al. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell 9, 147-161 (2010).
166. Frost, H. M. Micropetrosis. J. Bone Joint Surg. Am. 42, 144-150 (1960).
167. Sayer, A. A. et al. The developmental origins of sarcopenia. J. Nutr. Health Aging 12, 427-432 (2008).
168. Lamberts, S. W., van den Beld, A. W. & van der Lely, A. J. The endocrinology of aging. Science 278, 419-424 (1997). (Pubitemid 27454418)
169. Manolagas, S. C., Kousteni, S. & Jilka, R. L. Sex steroids and bone. Recent Prog. Horm. Res. 57, 385-409 (2002).
170. Hughes, D. E. et al. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat. Med. 2, 1132-1136 (1996).
171. Usui, M. et al. Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis. Proc. Natl Acad. Sci. USA 101, 6653-6658 (2004). (Pubitemid 38586029)
172. Chen, J. R. et al. Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens. J. Biol. Chem. 280, 4632-4638 (2005).
173. Kameda, T. et al. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J. Exp. Med. 186, 489-495 (1997). (Pubitemid 27360793)